(Q39642145)

English

CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.

scientific article published on 19 October 2010

Statements

CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. (English)
1 reference
Brian J Lannutti
1 reference
Sarah A Meadows
1 reference
Sarah E M Herman
1 reference
Adam Kashishian
1 reference
Bart Steiner
1 reference
Amy J Johnson
1 reference
Marc M Loriaux
1 reference
Mike Deininger
1 reference
Kamal D Puri
1 reference
Roger G Ulrich
1 reference
Neill A Giese
1 reference
19 October 2010
1 reference
117
1 reference
591-594
1 reference
2
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit